List of Excipients in API octreotide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing octreotide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | AMMONIA | |
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | FERROSOFERRIC OXIDE | |
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | GELATIN | |
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | GLYCERYL MONOCAPRYLATE | |
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | MAGNESIUM CHLORIDE | |
| Chiesi USA Inc | MYCAPSSA | octreotide | 10122-550 | METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing octreotide
Detailed excipient profiles for octreotide
Excipient focus: ACETIC ACID
octreotide drug variants containing ACETIC ACID
octreotide drug variants not containing ACETIC ACID
Excipient focus: AMMONIA
octreotide drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing AMMONIA
Excipient focus: FERROSOFERRIC OXIDE
octreotide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
octreotide drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing GELATIN
Excipient focus: GLYCERYL MONOCAPRYLATE
octreotide drug variants containing GLYCERYL MONOCAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing GLYCERYL MONOCAPRYLATE
Excipient focus: LACTIC ACID
octreotide drug variants containing LACTIC ACID
octreotide drug variants not containing LACTIC ACID
Excipient focus: LACTIC ACID, L-
octreotide drug variants containing LACTIC ACID, L-
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Mylan Institutional LLC | octreotide acetate | 67457-239 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing LACTIC ACID, L-
Excipient focus: MAGNESIUM CHLORIDE
octreotide drug variants containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing MAGNESIUM CHLORIDE
Excipient focus: MANNITOL
octreotide drug variants containing MANNITOL
octreotide drug variants not containing MANNITOL
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
octreotide drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: PHENOL
octreotide drug variants containing PHENOL
octreotide drug variants not containing PHENOL
Excipient focus: POLYSORBATE 80
octreotide drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE K12
octreotide drug variants containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing POVIDONE K12
Excipient focus: PROPYLENE GLYCOL
octreotide drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
octreotide drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
octreotide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM ACETATE
octreotide drug variants containing SODIUM ACETATE
octreotide drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM BICARBONATE
octreotide drug variants containing SODIUM BICARBONATE
octreotide drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM CAPRYLATE
octreotide drug variants containing SODIUM CAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM CAPRYLATE
Excipient focus: SODIUM CHLORIDE
octreotide drug variants containing SODIUM CHLORIDE
octreotide drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
octreotide drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Mylan Institutional LLC | octreotide acetate | 67457-239 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
octreotide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: TALC
octreotide drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
octreotide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRICAPRILIN
octreotide drug variants containing TRICAPRILIN
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing TRICAPRILIN
Excipient focus: TRIETHYL CITRATE
octreotide drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| >Company | >Ingredient | >NDC |
octreotide drug variants not containing TRIETHYL CITRATE
Excipient focus: WATER
octreotide drug variants containing WATER
octreotide drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Chiesi USA Inc | octreotide | 10122-550 |
| Amryt Pharmaceuticals Designated Activity Company | octreotide | 69880-120 |
| Fresenius Kabi USA LLC | octreotide acetate | 63323-365 |
| Fresenius Kabi USA LLC | octreotide acetate | 63323-377 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
